Jump to content

Modotuximab

From Wikipedia, the free encyclopedia
(Redirected from Zatuximab)
Modotuximab
Monoclonal antibody
TypeWhole antibody
SourceChimeric
TargetHER1
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG

Modotuximab (INN; formerly zatuximab) is a chimeric monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER1.[1]

References

[edit]
  1. ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).